Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rosa Fernández Bonifacio"'
Autor:
Blai Morales-Romero, José Manuel González de Aledo-Castillo, Cristina Fernández Sierra, Carmen Martínez Carreira, Carles Zaragoza Bonet, Rosa Fernández Bonifacio, Maria Antònia Caro Miró, Ana Argudo-Ramírez, Rosa María López Galera, Judit García-Villoria
Publikováno v:
Journal of Lipid Research, Vol 65, Iss 3, Pp 100516- (2024)
The gold-standard diagnostic test for peroxisomal disorders (PDs) is plasma concentration analysis of very long-chain fatty acids (VLCFAs). However, this method’s time-consuming nature and limitations in cases which present normal VLCFA levels nece
Externí odkaz:
https://doaj.org/article/ed20e2c3123846b6a8afee5fe6b88dba
Autor:
Patricia Rayo-Hidalga, Carlos Domingo-Bautista, Rosa Fernández Bonifacio, José Luis Bedini, Naira Rico
Publikováno v:
Advances in Laboratory Medicine / Avances en Medicina de Laboratorio.
Resumen Objetivos Atellica Solution (AS) es una plataforma que permite incorporar módulos de bioquímica e inmunoanálisis y almacenar controles de calidad internos (CC) en su interior gracias al módulo de refrigeración (MR). El objetivo del estud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f4da2a37c9573d8db772d127e5da624
https://doi.org/10.1515/almed-2022-0074
https://doi.org/10.1515/almed-2022-0074
Autor:
Javier Laguna, Rosa Fernández Bonifacio, Laura Macias-Muñoz, José Luis Bedini, Mª Dolors Salvia Roigés, Naira Rico
Publikováno v:
Clinical chemistry and laboratory medicineReferences. 60(11)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9148cf70832144fb5e1cbb887e5e294a
https://pubmed.ncbi.nlm.nih.gov/36030440
https://pubmed.ncbi.nlm.nih.gov/36030440
Publikováno v:
Pharmacogenomics and Personalized Medicine
Prostate cancer (PCa) is the second most common cancer in men worldwide. A large proportion of PCa are latent, never destined to progress or affect the patients’ life. It is of utmost importance to identify which PCa are destined to progress and wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f37e921f92b38ee25ad3b064f591e22
https://doi.org/10.2147/pgpm.s136026
https://doi.org/10.2147/pgpm.s136026
Autor:
Bernardino González de la Presa, Pere Llorens, Òscar Miró, Javier Jacob, Silvia Sandalinas, José Luis Bedini, Víctor Gil, Gregori Casals, Francisco Javier Martín-Sánchez, Martin Möckel, Rosa Fernández Bonifacio, Christian Mueller, Pablo Herrero-Puente
Publikováno v:
Biomarkers. 22:731-739
We tested the hypothesis that early measurement of galectin-3 at the emergency department (ED) during an episode of acute heart failure (AHF) allows predicting short- and long-term outcomes.We performed an exploratory study including 115 patients con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad672a609f59b821dade13c730e8cd92
https://doi.org/10.1080/1354750x.2017.1319421
https://doi.org/10.1080/1354750x.2017.1319421